← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 10, 2023Last known activity
Aug 20, 2025
Timeline
2010s
- Jun 1, 2018
HuidaGene Therapeutics Co., Ltd.— Founded
Drugs by trial phase (6 distinct, 8 trials)
Recent trials (15)
- NCT07063251OfficialEarly Phase 1Aug 20, 2025
- NCT07063251Lead sponsorEarly Phase 1Aug 20, 2025
- NCT06623279OfficialPhase 1Apr 1, 2025
- NCT06623279Lead sponsorPhase 1Apr 1, 2025
- NCT06615206Lead sponsorN/ANov 1, 2024
- NCT06594094OfficialN/AOct 30, 2024
- NCT06594094Lead sponsorN/AOct 30, 2024
- NCT06025032Lead sponsorEarly Phase 1Nov 30, 2023
- NCT06025032Study directorEarly Phase 1Nov 30, 2023
- NCT05906953Study directorPhase 1/Phase 2Oct 31, 2023
- NCT05906953OfficialPhase 1/Phase 2Oct 31, 2023
- NCT05906953Lead sponsorPhase 1/Phase 2Oct 31, 2023
- NCT06031727Study directorEarly Phase 1Sep 4, 2023
- NCT06031727Lead sponsorEarly Phase 1Sep 4, 2023
- NCT06088992CollaboratorEarly Phase 1Jan 10, 2023
Details
- Founded
- Shanghai, CN Jun 1, 2018
- Last known activity
- Aug 20, 2025